Cargando…
The adenosinergic signaling in the pathogenesis and treatment of multiple sclerosis
Multiple sclerosis (MS) is a highly disabling, progressive neurodegenerative disease with no curative treatment available. Although significant progress has been made in understanding how MS develops, there remain aspects of disease pathogenesis that are yet to be fully elucidated. In this regard, s...
Autores principales: | Duarte-Silva, Eduardo, Ulrich, Henning, Oliveira-Giacomelli, Ágatha, Hartung, Hans-Peter, Meuth, Sven G., Peixoto, Christina Alves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368763/ https://www.ncbi.nlm.nih.gov/pubmed/35967385 http://dx.doi.org/10.3389/fimmu.2022.946698 |
Ejemplares similares
-
The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis
por: Duarte-Silva, Eduardo, et al.
Publicado: (2023) -
Microbial Metabolites in Multiple Sclerosis: Implications for Pathogenesis and Treatment
por: Duarte-Silva, Eduardo, et al.
Publicado: (2022) -
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses
por: Chambers, Andrea M., et al.
Publicado: (2018) -
The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy
por: Kang, Chifei, et al.
Publicado: (2023) -
The CD39-Adenosinergic Axis in the Pathogenesis of Immune and Nonimmune Diabetes
por: Chia, Joanne S. J., et al.
Publicado: (2012)